" New methods to diagnose changing moles"

Slides:



Advertisements
Similar presentations
Distinguishing Pigmented Skin Lesions and Melanoma
Advertisements

Well differentiated squamous cell carcinoma, keratoacanthoma type (Keratoacanthoma): Three cases Deba P Sarma, MD Omaha.
Skin Pathology, Case 3 40 year-old female with no significant past medical history presents with a 1 cm pigmented lesion on the back. The borders are irregular.
AJCC Staging Moments AJCC TNM Staging 7th Edition Melanoma Case #1 Contributors: Jeffrey E. Gershenwald, MD University of Texas MD Anderson Cancer Center,
Introduction to Pathology. What is pathology Pathology is the scientific study of disease. In its broadest sense, it is the study of how the organs and.
Pancreas Cancer Nimisha K. Parekh, MD, MPH
The Natural History and Surgical Treatment of Primary Melanoma 2011 Phoenix Surgical Symposium John M. Kane III, MD Chief-Melanoma/Sarcoma Roswell Park.
Guidance on Cancer Services Improving Outcomes for People with Skin Tumours including Melanoma NICE Stateholder Consultation version July 2005.
Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery
What to Expect When a Lump Is Detected
Breast Imaging Made Brief and Simple
Tissue Sampling Options Lisa A. Newman, M.D., M.P.H., F.A.C.S. Professor of Surgery Director, Breast Care Center University of Michigan Ann Arbor, MI.
Casey Bower. What is Melanoma? Melanoma is the most common cancer in the United States and the most dangerous form of skin cancer, melanoma begins in.
Melanoma Olivia Wilson.
MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.
AJCC TNM Staging 7th Edition Melanoma Case #2
AJCC Staging Moments AJCC TNM Staging 7th Edition Melanoma Case #3 Contributors: Jeffrey E. Gershenwald, MD University of Texas MD Anderson Cancer Center,
Cancer is the 2 nd leading cause of death in the United States Cancer is uncontrolled abnormal cell growth. It can occur on the skin, body tissue, bone.
Assessment Of Diagnostic Accuracy Using A Digital Camera For Teledermatology.
Cutaneous Malignancies
Breast Cancer. What is this Disease? Second leading cause of cancer death in women Malignant (cancerous) tumor –Develops from cells in the breast that.
 Self-Examination  Clinical Examination  Mammography  Biopsy  Does prevailing ‘Standard of Care’ save lives? ©2012 Philip Hoekstra, PhD.
Maryam Sadeghi 1,3, Majid Razmara 1, Martin Ester 1, Tim K. Lee 1,2,3 and M. Stella Atkins 1 1: School of Computing Science, Simon Fraser University 2:
S KIN C ANCER Kathy Sheriff, RN, BSN. S KIN C ANCER One in five Americans Crucial risk factor—over exposure to UV radiation in sunlight Other cases, frequent.
DermaCompare- Early Detection of Melanoma. 2 Emerald Medical Applications Startup nation spirit Project launch Team members Edge of technology.
Maryam Sadeghi 1,3, Majid Razmara 1, Martin Ester 1, Tim K. Lee 1,2,3 and M. Stella Atkins 1 1: School of Computing Science, Simon Fraser University 2:
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
Pigmented nevi (moles) 29 patients, 41 lesions 17 benign nevi 18 dysplastic nevi 6 melanomas Control: adjacent normal skin Richard Langley et al., Mass.
FOH Presents… Skin Cancer
1 Cutaneous Melanoma MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.
Melanoma evaluation and management: expanding the role of the general practitioner in skin examination Meghan A. Rauchenstein February 16, 2006.
Understanding Cancer and Related Topics
v. # Breast Cancer Update Monita Soni, MD, FCAP-President, PrimePath, PC Decatur, AL CAP Spokesperson November 2010.
Melanoma: assessment and management NICE guideline NG14 Full guideline July 2015.
“Rapid and uncontrollable development and production of cells”
Introduction to Tumor Board
Dermatoscope.
Mark Browning, M.D. IUSME.  Intermittent high exposure to the sun is a major risk  Other risk include a family history and an increased number.
CELL DIVISION GOING WRONG: Cancer When cells grow and divide out of control, they cause a group of diseases called cancer.cancer The result is a change.
C LASSIFICATION OF SKIN LESIONS IN DERMOSCOPY IMAGES Ana Raimundo Jorge Martins Júlia Pinheiro Ricardo Trindade Introdução à Engenharia.
Annals of Oncology 23: 298–304, 2012 종양혈액내과 R4 김태영 / prof. 김시영.
Melanoma Raising Awareness. Quick Facts About 68,720 people were diagnosed with melanoma in ,650 died of melanoma Melanoma accounts for 3% of skin.
Skin Cancer and Malignant Melanoma
MALIGNANT MELANOMA. Outline Introduction Aetiology Types Invasion and Metastasis Risk Factors Diagnosis and Staging Treatment and Prevention.
MELANOMA Stephen G. Mallette, D.O. Athens, Alabama.
Date of download: 9/18/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Selection of Patients for Long-term Surveillance.
Squamous Cell Carcinoma
“Know the Skin You’re In”
Dermoscopy of acral pigmented lesions
Management of Thyroid Nodules Detected at US: Society of Radiologists in Ultrasound Consensus Conference Statement Radiology 2005; 237: Presented.
MALIGNANT MELANOMA.
Dermoscopy curriculum: Introduction
CELL DIVISION GOING WRONG: Cancer
SKIN CANCER PREVENTION & EARLY DETECTION SAVES LIVES
Copyright © 2013 American Medical Association. All rights reserved.
moletest Update for TDUF Meeting on 28 Aug 2014
VALUES OF ELASTOGRAPHY IN DIAGNOSIS OF THYROID CANCER
SKIN CANCER NOTES.
Treatment Overview: The Multidisciplinary Team
‘Improving Outcomes for people with skin tumours, including Melanoma’
Doctor, is this “mole” anything to worry about?
Breast Cancer.
CELL DIVISION GOING WRONG: Cancer
Cancer 101: A Cancer Education and Training Program for [Target Population] Date Location Presented by: Presenter 1 Presenter 2 1.
S. Borsari1, R. Pampena1, E. Benati1, C. Bombonato1, A. Kyrgidis1, E
Clinical, dermatoscopical and histopathological correlation of atypical actinic keratoses ID21905 Alise Balcere1, Raimonds Karls, Māris Sperga1, Māra Rone.
Presentation transcript:

" New methods to diagnose changing moles" Zsolt B. Argenyi, M.D. Professor of Pathology & Dermatology Director of the Pigmented Lesion Clinic and Dermatopathology University of Washington Medical Center Seattle, WA, USA

Why to Strive for an Early Diagnosis? … and some more statistics Long term survival is greater than 90% with thin (<1mm) melanoma. Long term survival is 50-90% with thick (>1mm) melanoma Long term survival is 20-60% with lymph node involvement Long term survival is less than 10% with distant metastasis. Diagnosis in early stages  good survival

Improved identification Some Encouraging News 65% of patients are diagnosed with localized disease Goal Better patient profiling Improved identification techniques Earliest possible diagnosis

Skin self-examination The Good News (cont.) Improved identification techniques Skin self-examination Dermoscopy Total body skin photography

Traditional Clinical Examination A: Asymmetry B: Border irregularity C: Colors D: Diameter > 6 mm E: Evolving lesions

Why Dermoscopy? ABCD criteria are not always reliable Common atypical looking, but benign lesions Poor discrimination between pigmented melanocytic and pigmented non-melanocytic lesions Unnecessary biopsies and surgeries

Dermatoscopy – Epiluminescence Microscopy Non-invasive, in-vivo microscopic technique using incident light, immersion oil, and low-to-medium power magnifying optics Helpful to differentiate pigmented melanocytic from pigmented non-melanocytic lesions Increases diagnostic accuracy of pigmented lesions Widely used in Europe Becoming routine use in the USA

Principles of Dermoscopy New morphology appears with features that cannot be perceived by the naked eye

Dermoscopic Diagnosis of Melanocytic Tumors High sensitivity 75-96% High specificity 79-98% This improves with experience and far exceeds the rate by clinical examination alone

Recently Introduced Application of Dermoscopy on Equivocal Lesions “Short Term Mole Monitoring” Low concern lesions on clinical exam Newly developed lesions More of a concerns for the patient 3-4 months dermoscopic monitoring Lesions are removed if further changes occur

. The diagnostic software of this computer analyzes the images by comparing to a large data bank and provides a diagnostic score. The diagnostic score correlates with the biologic behavior of the lesion benign vs. malignant.

Based on the biopsy report, your Dermatologist will advise you if further treatments are needed.

Skin Surface Microscopy Image Analysis Colors Structures Patterns Criteria Clinico-pathologic correlation Diagnosis

Algorithmic Approach of Pigmented Skin Lesions

The Patient - Physician Team Work Periodic Exams with Multiple Techniques Skin self-examination Dermoscopy Total body skin photography

The Importance of Total Body Photography High-resolution digital overview photos of the entire skin surface Standardized technique, lighting, distance, topography, etc. Baseline record used for follow-up examination for comparison to detect new or changing lesions One set for patient clinic records, another set for patient’s own records for self-exams

Total Body Photography Marghoob te al. J Am Acad Dermatol 2003; 777-97.

Patients Who Benefit from TBP Personal or family history of melanoma “Atypical mole syndrome” Multiple normal appearing nevi Large congenital nevi Genetic abnormalities (p16 gene) High anxiety

Advantages of TBP Help to identify new or changing lesions Increase the efficiency of biopsying the right lesion May save the life by earlier detection

Additional Advantages of TBP Encouraging participation by involving self-screening Reducing unnecessary biopsy rates for benign nevi Reassuring patients that stable lesions are benign

Maximazing Positive Outcome Goal Better patient profiling Improved identification techniques Earliest possible diagnosis

Combination of Approaches Optimize knowledge, resources, and techniques. Select the high risk patient population Combining techniques Total body photography Dermoscopy Invest and develop new techniques In vivo confocal scanning microscopy Teledermatology

Melanoma in situ Margins !

Mobile Teledermatology C.Ebner et al. J.Telemed. Telecare 2008

Combination of Approaches (cont.) Collaborate with the full scale of multidisciplinary specialists: Dermatologists Surgeons Clinical oncologists Pathologists, dermatopathologists Psychiatrists Researchers Social Workers and Survivors and their relatives

Beyond the Hard Core Science Pearls from Real Survivors Emotional commitment to keep going despite ups and downs Utilize all internal and external resources Positive thinking Goal setting, being creative Find humor and playfulness Share experiences and learn from others Comply with Doctor’s instructions Appreciate life Living everyday in the fullest sense